Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Immediate postoperative measurement of thyroid-stimulating hormone as an early predictor of remission in thyroid-stimulating hormone?secreting pituitary adenomasImmediate postoperative measurement of thyroid-stimulating hormone as an early predictor of remission in thyroid-stimulating hormone–secreting pituitary adenomas

Other Titles
Immediate postoperative measurement of thyroid-stimulating hormone as an early predictor of remission in thyroid-stimulating hormone–secreting pituitary adenomas
Authors
Kim, Soo HeonKu, Cheol RyongYoo, JihwanNa, MinkyunKim, WoohyunJung, In-HoKim, Kyung WonMoon, Ju HyungKim, DahamLee, Eun JigKim, Sun HoKim, Eui Hyun
Issue Date
Mar-2020
Publisher
AMER ASSOC NEUROLOGICAL SURGEONS
Keywords
hyperthyroidismpituitary adenomaremissionthyroid-stimulating hormonetranssphenoidal surgerypituitary surgery
Citation
JOURNAL OF NEUROSURGERY, v.134, no.3, pp.794 - 800
Indexed
SCIE
SCOPUS
Journal Title
JOURNAL OF NEUROSURGERY
Volume
134
Number
3
Start Page
794
End Page
800
URI
https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/190703
DOI
10.3171/2020.1.jns192787
ISSN
0022-3085
Abstract
OBJECTIVE Thyroid-stimulating hormone (TSH)-secreting pituitary adenoma (TSHoma) is a rare type of pituitary adenoma; thus, little is known about TSHomas. The purpose of this study was to analyze clinical characteristics and therapeutic outcomes of TSHomas based on a single-center experience. The authors also searched for reliable preoperative and early postoperative factors that could predict long-term endocrinological remission. METHODS The clinical, radiological, and pathological characteristics and surgical and endocrinological outcomes of 31 consecutive cases of TSHomas that were surgically treated between 2005 and 2017 were reviewed retrospectively. Preoperative factors were evaluated for their ability to predict long-term remission by comparing remission and non remission groups. TSH and free thyroxine levels were measured at 2, 6, 12, 18, and 24 hours after surgery to determine whether they could predict long-term remission. RESULTS Gross-total removal of tumor was achieved in 28 patients (90.3%), and 26 patients (83.9%) achieved endocrinological remission by surgery alone based on long-term endocrinological follow-up (median 50 months, range 32-81 months). The majority of the tumors were solid (21/31, 67.7%), and en bloc resection was possible in 16 patients (51.6%). Larger tumor size and tumor invasion into cavernous sinus and sphenoid sinus were strong predictors of lower rates of endocrinological remission. Immediate postoperative TSH level at 12 hours after surgery was the strongest predictor, with a 0.62 mu IU/mL cutoff. Postoperative complications included CSF rhinorrhea in one patient and epistaxis in another patient, who underwent additional surgical treatment for the complications. CONCLUSIONS Tumor size and extent are major prognostic factors for both extent of resection and endocrinological remission. The consistency of TSHomas was more likely to be solid, which makes extracapsular dissection more feasible. Long-term remission of TSHomas could be predicted even during the early postoperative period. https://thejns.org/doi/abs/10.3171/2020.1.JNS192787
Files in This Item
Go to Link
Appears in
Collections
서울 의과대학 > 서울 신경외과학교실 > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Na, Minkyun photo

Na, Minkyun
COLLEGE OF MEDICINE (DEPARTMENT OF NEUROSURGERY)
Read more

Altmetrics

Total Views & Downloads

BROWSE